| CASE REPORT |
|
| Year : 2017 | Volume
: 6
| Issue : 2 | Page : 445-446 |
|
|
Candidate for a live vaccine?
Justin Ralph Abbatemarco1, Alan Taege2
1 Neurological Institute, Cleveland Clinic Foundation, Cleveland, Ohio, USA
2 Department of Infectious Disease, Cleveland Clinic Foundation, Cleveland, Ohio, USA
Correspondence Address:
Dr. Justin Ralph Abbatemarco
Cleveland Clinic, 9500 Euclid Ave S100A, Cleveland, OH 44195
USA
 Source of Support: None, Conflict of Interest: None  | Check |
DOI: 10.4103/jfmpc.jfmpc_67_17
|
|
|
Immune dysfunction is a well-known phenomenon in end-stage liver disease (ESLD). The pretransplant period offers a unique window for primary care physicians to optimize the transplant's vaccine protection before antirejection medications are initiated. Live vaccinations are selected cautiously but the varicella-zoster virus (VZV) vaccine, Zostavax, is recommended for pretransplant candidates. This case highlights an ESLD patient who developed disseminated cutaneous VZV within 30 days of vaccination.
|
|
|
|
| [FULL TEXT] [PDF]* |
|
 |
|
